header

The predictive value of fats (fragile-site associated tumor suppressor) gene expression on the sensitivity of cisplatin in advanced non-small cell lung cancer / (Record no. 55154)

MARC details
000 -LEADER
fixed length control field 02929cam a2200349 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GiCUC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250223031429.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160223s2015 ua d f m 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-GiCUC
Language of cataloging eng
Transcribing agency EG-GiCUC
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Deposite
097 ## - Thesis Degree
Thesis Level Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Cai01.19.04.Ph.D.2015.Ah.P
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Ahmed Magdy Rabea
245 14 - TITLE STATEMENT
Title The predictive value of fats (fragile-site associated tumor suppressor) gene expression on the sensitivity of cisplatin in advanced non-small cell lung cancer /
Statement of responsibility, etc. Ahmed Magdy Rabea ; Supervised Rabab Mohamed Gaafar , Ola Mohamed Khorshid , Ayman Abdelsamie Gaber
246 15 - VARYING FORM OF TITLE
Title proper/short title فى الحالات المتقدمة لسرطان الرئة ذو الخلايا الغير صغيرة المعالجة بعقار السيسبلاتين (Fragile-Site Associated Tumor Suppressor) استخدام الجين
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cairo :
Name of publisher, distributor, etc. Ahmed Magdy Rabea ,
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 132 P. :
Other physical details charts ;
Dimensions 25cm
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Medical Oncology
520 ## - SUMMARY, ETC.
Summary, etc. Patients and methods: A prospective longitudinal study has been conducted in NCI (National Cancer Institute) medical oncology department in outpatient setting, in the period between June 2012 and July 2014. The study included 70 patients with pathologically proven advanced (stage IIIB and IV) non-small cell lung cancer (NSCLC) treated with cisplatin and gemcitabine. FATS gene expression was measured before starting the treatment. The primary end point was overall response rate (ORR) while the secondary end point was progression free survival (PFS) and overall survival (OS).Results: Seventy patients were assessed and included in the trial. Thirteen patients achieved partial response while 13 patients achieved stable disease and the rest had a progressive disease. The overall response rate was statistically significant (p-value 0.031) for the high FATS expression group. The median PFS was 4.1 months (95% CI 2.1-6.2) in the low expression group and 3.8 months (95% CI 3.3-4.3) in the high expression group (p-value 0.442) while median OS was 6.9 months (95% CI 5.4-8.3) in the high expression group and 4.5 months (95% CI 3.7-5.3) in the low expression group (p-value 0.031)Conclusion: The expression of the FATS gene can have an implication on the response to cisplatin and the overall survival. This opens the opportunity that FATS gene can be used as a predictive marker for NSCLC patients receiving cisplatin and gemcitabine chemotherapy
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Issued also as CD
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Cisplatin
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term FATS
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term NSCLC
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Ayman Abdel Samie Gaber ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Ola Mohamed Khorshid ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Rabab Mohamed Gaafar ,
Relator term
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a>
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Enas
Reviser Cataloger
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Nazla
Reviser Revisor
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Holdings
Source of classification or shelving scheme Not for loan Home library Current library Date acquired Full call number Barcode Date last seen Koha item type Copy number
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 11.02.2024 Cai01.19.04.Ph.D.2015.Ah.P 01010110068038000 22.09.2023 Thesis  
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة مخـــزن الرســائل الجـــامعية - البدروم 11.02.2024 Cai01.19.04.Ph.D.2015.Ah.P 01020110068038000 22.09.2023 CD - Rom 68038.CD